HCG Launches Comprehensive Cancer Hospital in North Bengaluru with Karnataka's First MR-Linac

HCG Launches Comprehensive Cancer Hospital in North Bengaluru with Karnataka's First MR-Linac

HCG Launches Comprehensive Cancer Hospital in North Bengaluru with Karnataka's First MR-Linac​

HealthCare Global Enterprises Limited (HCG), India's largest dedicated cancer hospital network, has launched a new comprehensive cancer hospital facility in Byatarayanapura (Hebbal), North Bengaluru. The new center significantly strengthens access to advanced oncology care in North Bengaluru, positioning itself as a major advancement in the region's cancer treatment landscape.

The new facility introduces Karnataka's first Elekta Unity MR-Linac, a state-of-the-art radiation therapy platform. This advanced technology integrates high-quality MRI imaging with a linear accelerator, enabling highly precise, adaptive cancer treatment. The hospital is designed as a full-spectrum oncology center, bringing diagnosis, treatment, recovery support, and patient-centric care under one roof.

The new Hebbal facility, which accommodates up to 132 beds, marks a major milestone in precision oncology. Dr. B. S. Ajaikumar, Founder and Chairman of HealthCare Global Enterprises Limited, highlighted that the launch brings state-of-the-art infrastructure and the region's first MR-Linac technology, reinforcing HCG's commitment to making advanced oncology care more accessible.

Dr. Manish Mattoo, Executive Director and CEO of HCG, stated that the center brings together people-centric care, multidisciplinary expertise, preventive focus, and advanced technology. He noted that with the MR-Linac, HCG is introducing a major upgrade to its oncology services, making technology-first cancer care more accessible, particularly for residents of Karnataka.

Advanced Infrastructure and Capabilities​

The hospital is equipped with several cutting-edge tools to support comprehensive cancer management. Infrastructure includes:

  • Diagnostic Imaging: An 80-slice Digital PET-CT scanner for precise, high-resolution diagnostic imaging.
  • Advanced Radiation Therapy: Elekta Unity MR-Linac and Accuray TomoTherapy with Radixact.
  • Operational Units: Five robotic-assisted modular operation theatres, 19 chemotherapy daycare beds, 14 premium treatment bays, and a 15-bed ICU and HDU.

In addition to specialized equipment, the facility supports a wide array of diagnostic and clinical services, including endoscopy, bronchoscopy, ultrasound, X-ray, mammography, advanced laboratories, histopathology, frozen section services, and blood storage. The facility boasts a total built up area of 1,75,086 Sqft.

According to Ms. Manisha Kumar, COO, Karnataka, HCG Cancer Hospital, the launch marks an important milestone in HCG’s continued commitment to expanding advanced cancer care access in Bengaluru. Sachin S.E., COO, HCG Cancer Hospital Hebbal, added that the center was designed to move away from a conventional clinical environment, creating spaces that inspire comfort, confidence, and hope, while leveraging the MR-Linac to deliver precise, personalized treatment.

HCG, headquartered in Bengaluru, is noted as the largest dedicated cancer hospital network in India. The company operates a network of 25 comprehensive cancer hospitals across India and Africa, providing advanced cancer care under one roof.

HCG Stock Price Movement​

Healthcare Global Enterprises Limited shares closed today, gaining 2.73% on the momentum to settle at ₹646.85. Trading activity was notably robust through the session, with the stock moving on a volume of 132,428 shares.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top